Travere Therapeutics Announces Full FDA Approval of FILSPARI® (sparsentan), the First and Only Approved Medicine for FSGS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/30/2026

1. NTAP
2. SPY
3. MDB
4. NVDA
5. META
6. FFAI
7. ORCL
8. MTN
9. AIR
10. SMMT

Go back to Travere Therapeutics Announces Full FDA Approval of FILSPARI® (sparsentan), the First and Only Approved Medicine for FSGS
(NASDAQ: TVTX) Delayed: 59.99 --0 (-0%)
Previous Close $59.99    52 Week High $ 
Open $59.99    52 Week Low $ 
Day High $59.99    P/E N/A 
Day Low $59.99    EPS $ 
Volume 3,535